RedHill Biopharma Secured U.S. Government Funding through BARDA to Advance Opaganib for Ebola Treatment
On Oct. 14, 2024, RedHill Biopharma announced that the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA)…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | Medicine | Therapeutics | WHO
WHO reported Increase in Rwanda Marburg virus disease incidence
On Oct. 11, 2024, the World Health Organization (WHO) reported that a total of 58 cases of Marburg…
Study during DR Congo’s outbreak found 84% protection from Ebola vaccine
On Aug. 21, 2024, French and Democratic Republic of the Congo (DRC) researchers announced that a real-world study…
Biotechnology | COVID-19 | Influenza | Life Science News | Plague | Vaccine | WHO
CEPI and WHO urge broader research strategy for countries to prepare for the next pandemic
On Aug. 1, 2024, the Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health Organization (WHO) called…
![European Commission expanded Merck’s ERVEBO [Ebola Zaire vaccine] indication to include children 1 year of age and older](https://www.lifesciencehistory.com/wp-content/uploads/2022/06/european_commission_logo-768x768.jpg){kind=logo}
European Commission expanded Merck’s ERVEBO [Ebola Zaire vaccine] indication to include children 1 year of age and older
On Sept. 7, 2023, Merck announced that the European Commission (EC) had approved an expanded indication for ERVEBO…
U.S. FDA approved Merck’s ERVEBO (Ebola Zaire Vaccine, Live) for use in children 12 months of age and older
On Aug. 3, 2023, Merck announced that the U.S. Food and Drug Administration (FDA) had approved an expanded…
U.S. FDA approved Ervebo first U.S.-licensed vaccine for prevention of Ebola virus disease
On Jul. 28, 2023, the U.S. Food and Drug Administration (FDA) approved Merck’s Ervebo, a vaccine for the…
Biotechnology | Disease | Life Science News | NIH | Therapeutics | Vaccine
Experimental NIH Sudan virus vaccine protected Macaques
On Feb. 2, 2023, a National Institutes of Health research group with extensive experience studying ebolavirus countermeasures successfully…
Uganda declared end of Ebola disease outbreak
On Jan. 11, 2023, Uganda declared the end of the Ebola disease outbreak caused by Sudan ebolavirus, less…
Oxford Ebola vaccine manufactured and shipped in record time by Serum Institute of India
On Dec. 15, 2022, the University of Oxford Oxfordï¾’s Ebola vaccine candidate has been shipped to Uganda, just…
Ebola trial candidate vaccines arrived in Uganda in record 79 days after outbreak declared
On Dec. 9, 2022, the WHO announced that the first doses of one of the three candidate vaccines…
Uganda declared Ebola virus disease outbreak
On Sept. 20, 2022, The health authorities in Uganda declared an outbreak of Ebola after a case of…
Democratic Republic of the Congo Ebola outbreak declared over, Uganda boosted response
On Sept. 17, 2022, the Democratic Republic of the Congo declared the end of an Ebola outbreak that…
WHO reported Ebola virus disease in Democratic Republic of the Congo
On Apr. 28, 2022, the Ministry of Health of the Democratic Republic of the Congo declared an outbreak…
Democratic Republic of the Congo declared Ebola outbreak over
On Dec. 16, 2021, the Ebola outbreak that erupted in the Democratic Republic of the Congo’s North Kivu…
Cote d’Ivoire declared first Ebola outbreak in more than 25 years
On Aug. 14, 2021, the Ministry of Health of Cote d’Ivoire confirmed the country’s first case of Ebola…
West Africa’s first-ever case of Marburg virus disease confirmed in Guinea
On Aug. 9, 2021, health authorities in Guinea confirmed a case of Marburg virus disease in the southern…
Ebola outbreak in Guinea declared over
On Jun. 19, 2021, the Ebola outbreak that emerged in Guinea in mid-February was declared over. It was…
The 12th Ebola outbreak in the Democratic Republic of the Congo declared over
On May 3, 2021, the World Health Organization (WHO) announced the end of the 12th outbreak of Ebola…
Ebola outbreak declared in Guinea
On Feb. 14, 2021, the WHO announced that Health authorities in Guinea had declared an outbreak of Ebola…
Reston Ebolavirus spreads efficiently in pigs
On Dec. 21, 2020, the NIH announced a study published in Proceedings of the National Academy of Sciences…
Regeneron’s antibody cocktail REGN-EB3 (Inmazeb) first FDA-approved treatment for Ebola (Zaire Ebolavirus)
On Oct. 14, 2020, Regeneron announced that the FDA had approved Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) for the…
FDA approved first treatment for Ebola virus
On Oct. 14, 2020, the FDA approved Regeneron Pharmaceutical’s Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three…
Rapid diagnostic detected Lassa and Ebola in real-time
On Aug. 26, 2020, researchers announced an inexpensive, sensitive, CRISPR-based tests diagnose two deadly viruses in settings with…
Johnson & Johnson received positive CHMP opinion for Janssen’s investigational preventive Ebola vaccine regimen
On May 29, 2020, Johnson & Johnson announced that its Janssen Pharmaceutical subsidiary received a positive opinion from…
Soligenix and University of Hawaii at Manoa initiate work on novel Coronavirus vaccine for COVID-19
On Mar. 23, 2020, Soligenix announced that its ongoing collaboration with the University of Hawaii at Manoa (UH…
Biotechnology | Infectious Disease | Life Science News | Medicine | NIH | Non-Profit Research | Vaccine
UNMC awarded $12 million grant by the Dept of HHS to establish and co-lead the nation’s National Ebola Training and Education Center
On Jul. 1, 2015, the UNMC/Nebraska Medicine, in collaboration with Emory University in Atlanta and Bellevue Hospital Center…
Biotechnology | CDC | Diagnostics | Infectious Disease | Life Science News | Medicine | NIH | Therapeutics | Vaccine | WHO
The CDC responded to the West Africa Ebola outbreak
On Feb. 27, 2015, the U.S. Centers for Disease Control and Prevention (CDC) responded to the West Africa…
Biotechnology | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
Philanthropist Paul G Allen donated $100 million to fight Ebola
On Oct. 23, 2014, philanthropist Paul G. Allen donated $100 million to fight Ebola and called on the…
Biotechnology | CDC | Diagnostics | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
The Centers for Disease Control and Prevention confirmed the first Ebola case in Dallas, Texas
On Sept. 30, 2014, the Centers for Disease Control and Prevention confirmed that Eric Duncan, a Liberian national…